US Broker Ratings

Insmed Incorporated (INSM) Stock Analysis: A Biotech Powerhouse with a 52.80% Upside Potential

Insmed Incorporated (NASDAQ: INSM) is a formidable player in the biotechnology sector, demonstrating remarkable growth potential and attracting significant attention from investors and analysts alike. With..

Jazz Pharmaceuticals (JAZZ): Investor Outlook on a Biotech Powerhouse with a 9.51% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a notable player in the healthcare sector, is making waves in the biotechnology industry with its robust portfolio of pharmaceutical products..

ADMA Biologics Inc (ADMA): Investor Outlook Highlights 71.72% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, is drawing significant attention from investors with a compelling potential upside of 71.72%. With..

Takeda Pharmaceutical Co. (TAK) Stock Analysis: Exploring a 22.88% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a significant player within the healthcare sector, operating in the niche domain of drug manufacturing, including both specialty..

Nuvalent, Inc. (NUVL) Stock Analysis: Navigating Biotech’s Uncharted Waters with Zero Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, stands at the forefront of innovation in cancer therapy development. Specializing in creating therapies..

Waystar Holding Corp. (WAY) Stock Analysis: Why Analysts See a 37% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare information services sector, capturing investor attention with a robust 37.45% potential upside according to recent..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a 10.70% Upside Potential with Solid Revenue Growth

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, is capturing investor attention with its robust revenue growth and a potential upside of..

Cardinal Health (CAH) Stock Analysis: 6.77% Potential Upside Amid Robust Revenue Growth

Cardinal Health, Inc. (NYSE: CAH), a pivotal player in the healthcare sector, is capturing investor attention due to its promising potential upside and robust revenue growth...

HealthEquity, Inc. (HQY) Stock Analysis: Investor Optimism with 13% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the healthcare sector, is drawing significant attention from investors with its robust service offerings and potential upside. With..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Promising 32.94% Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a noteworthy player in the biotechnology industry, is capturing investor attention with its promising potential for a 32.94% upside, as indicated..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 16.64% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $30.74..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 10% Upside Potential in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is firmly positioned within the medical devices industry, offering a compelling narrative for investors seeking..

AstraZeneca PLC (AZN) Stock Analysis: Unveiling a 32% Potential Upside Amid Strong Buy Ratings

AstraZeneca PLC (AZN), a leading biopharmaceutical titan based in Cambridge, UK, is making waves in the healthcare sector with its robust pipeline of prescription medicines. With..

Corcept Therapeutics (CORT) Stock Report: A Potential 22% Upside Amid Robust Revenue Growth

Corcept Therapeutics Incorporated (CORT) presents a compelling investment opportunity in the biotechnology sector, particularly for those keen on high-growth potential. With a market capitalization of $11.97..

Edwards Lifesciences Corporation (EW) Stock Analysis: Strong Buy Ratings Signal 12.53% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a substantial market capitalization of..

Chemed Corp (CHE) Stock Analysis: Navigating High Valuation with Sustainable Growth Potential

Chemed Corp (NYSE: CHE), a stalwart in the healthcare sector, has carved out a niche in the medical care facilities industry. With a market capitalization of..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Potential Amidst a -14.07% Downside

Moderna, Inc. (NASDAQ: MRNA) has become a household name in the biotechnology sector, particularly due to its mRNA technology that revolutionized vaccine development during the COVID-19..

BeOne Medicines Ltd. (ONC) Stock Analysis: 23.95% Potential Upside Captures Investor Attention

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry, is generating significant buzz among investors. With a market capitalization of $39.4 billion and a..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 30% Upside Potential with Strong Buy Ratings

Neurocrine Biosciences, Inc. (NBIX), a leading player in the healthcare sector, is increasingly capturing the attention of investors with its robust growth metrics and promising pipeline...

Cigna Group (CI) Stock Analysis: Unpacking the 20.86% Potential Upside for Investors

For investors eyeing opportunities in the healthcare sector, The Cigna Group (NYSE: CI) presents a compelling case with a potential upside of 20.86%. As a major..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds